secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vera Therapeutics, Inc. (VERA)
CIK:        0001831828
Form:       8-K
Filed at:   2021-12-15T23:59:59+00:00
Accession:  0001193125-21-357463
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Vera Therapeutics appoints Kimball Hall to board of directors
-------------------------------------------------------------

- Kimball Hall appointed to Board effective December 10, 2021 as Class I director.
- Granted stock option for 19,850 shares vesting monthly over 3 years.
- Annual cash retainer of $35,000, pro-rated for 2021.
- Eligible for annual option grant of 9,925 shares starting 2022 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831828/000119312521357463/0001193125-21-357463-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831828/000119312521357463/d274787d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-357463

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer